91 related articles for article (PubMed ID: 12608580)
1. Overexpression and increased DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani.
Jayanarayan KG; Dey CS
Microbiol Res; 2003; 158(1):55-8. PubMed ID: 12608580
[TBL] [Abstract][Full Text] [Related]
2. Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani.
Singh G; Jayanarayan KG; Dey CS
Mol Biochem Parasitol; 2005 May; 141(1):57-69. PubMed ID: 15811527
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile.
Singh G; Thakur M; Chakraborti PK; Dey CS
Int J Antimicrob Agents; 2009 Jan; 33(1):80-5. PubMed ID: 18805675
[TBL] [Abstract][Full Text] [Related]
4. Putative P-glycoprotein expression in arsenite-resistant Leishmania donovani down-regulated by verapamil.
Kaur J; Dey CS
Biochem Biophys Res Commun; 2000 May; 271(3):615-9. PubMed ID: 10814510
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani.
Singh G; Dey CS
Acta Trop; 2007 Sep; 103(3):172-85. PubMed ID: 17655815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.
Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK
Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238
[TBL] [Abstract][Full Text] [Related]
7. Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania.
Lee N; Gannavaram S; Selvapandiyan A; Debrabant A
Eukaryot Cell; 2007 Oct; 6(10):1745-57. PubMed ID: 17715367
[TBL] [Abstract][Full Text] [Related]
8. Altered expression, polymerisation and cellular distribution of alpha-/beta-tubulins and apoptosis-like cell death in arsenite resistant Leishmania donovani promastigotes.
Jayanarayan KG; Dey CS
Int J Parasitol; 2004 Jul; 34(8):915-25. PubMed ID: 15217730
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
10. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
Saxena D; Yiu GK; Ni X; Huang KC; Mantovani R; Jacquemin-Sablon AG; Ng SW
Gene; 2004 Nov; 342(1):145-55. PubMed ID: 15527974
[TBL] [Abstract][Full Text] [Related]
11. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
Kubo T; Kohno K; Ohga T; Taniguchi K; Kawanami K; Wada M; Kuwano M
Cancer Res; 1995 Sep; 55(17):3860-4. PubMed ID: 7641205
[TBL] [Abstract][Full Text] [Related]
13. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
Khélifa T; Casabianca-Pignède MR; René B; Jacquemin-Sablon A
Mol Pharmacol; 1994 Aug; 46(2):323-8. PubMed ID: 8078494
[TBL] [Abstract][Full Text] [Related]
14. Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.
Sengupta T; Mukherjee M; Mandal C; Das A; Majumder HK
Nucleic Acids Res; 2003 Sep; 31(18):5305-16. PubMed ID: 12954766
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH
Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202
[TBL] [Abstract][Full Text] [Related]
16. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
17. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.
Sengupta T; Mukherjee M; Das R; Das A; Majumder HK
Nucleic Acids Res; 2005; 33(8):2364-73. PubMed ID: 15860773
[TBL] [Abstract][Full Text] [Related]
19. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
Ray S; Hazra B; Mittra B; Das A; Majumder HK
Mol Pharmacol; 1998 Dec; 54(6):994-9. PubMed ID: 9855627
[TBL] [Abstract][Full Text] [Related]
20. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.
Matsumoto Y; Takano H; Fojo T
Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
